Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Fernando López-Calderón
Cdk4/6-Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status
Clinical Cancer Research
Cancer Research
Oncology
EZH2 in Bladder Cancer, a Promising Therapeutic Target
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Related publications
Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma
International Journal of Oncology
Cancer Research
Oncology
Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer
Breast Care
Surgery
Oncology
A Novel Tankyrase Inhibitor, MSC2504877, Enhances the Effects of Clinical CDK4/6 Inhibitors
Scientific Reports
Multidisciplinary
Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression
Molecular Cancer Therapeutics
Cancer Research
Oncology
CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER2 + Breast Cancer
Cancer Cell
Cancer Research
Oncology
Cell Biology
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib
PLoS ONE
Multidisciplinary
P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib
Management of Adverse Events During Cyclin-Dependent Kinase 4/6 (CDK4/6) Inhibitor-Based Treatment in Breast Cancer
Therapeutic Advances in Medical Oncology
Oncology
